Pociredir

N/A

Report date: 2026/04/15 20:02:38
NME

Base Information

Drug NamePociredir
Drug Alias NameFTX HbFFTX-6058
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPolycomb protein EED inhibitorsFetal hemoglobin inducers
TargetsPolycomb protein EEDFetal hemoglobin
Therapy Area/Indicationsbeta-ThalassemiaAnemia, Sickle Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSouth AfricaNigeria
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesFulcrum Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesFulcrum Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAnemia, Sickle Cell
Inactive Indicationsbeta-Thalassemia

Other Information

ATC CodeN/A
Related LinksN/A